AS ONE Corporation
Stock Price Chart
2026/05/11 UpdatedPrice Trend
2026/05/11 UpdatedPrice & Trading Details
2026/05/11 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/05/01Earnings Calendar
Updated 2026/05/01Shareholder Composition
Updated 2026/05/01Major Holders
Updated 2026/05/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
First Eagle Funds-First Eagle Overseas Fund
|
3.5M | +19.48% | |
|
MFS Series Trust V-MFS International New Discovery Fund
|
3.1M | +20.42% | |
|
Virtus Opportunities Trust-Virtus KAR International Small-Mid Cap Fund
|
2.1M | 0.00% | |
|
Fidelity Investment Trust-Fidelity International Small Cap Fund
|
2.0M | 0.00% | |
|
SmallCap World Fund Inc
|
1.7M | 0.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
844.9K | 0.00% |
Dividend History
Updated 2026/05/10| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥32 | -50.8% |
| 2025 | ¥65 | +10.2% |
| 2024 | ¥59 | +4.4% |
| 2023 | ¥57 | +11.9% |
| 2022 | ¥51 | - |
Financial Performance
2026/05/10 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥86,954M | ¥91,422M | ¥95,536M | ¥103,751M |
| Gross Profit | ¥25,544M | ¥28,450M | ¥29,249M | ¥31,315M |
| Operating Income | ¥9,342M | ¥11,396M | ¥10,436M | ¥11,594M |
| Pretax Income | ¥10,457M | ¥11,671M | ¥10,829M | ¥11,835M |
| Net Income | ¥7,203M | ¥8,113M | ¥7,500M | ¥8,229M |
| EPS | ¥96.20 | ¥109.30 | ¥103.50 | ¥114.72 |
| Operating Margin | 10.74% | 12.47% | 10.92% | 11.17% |
| Balance Sheet | ||||
| Total Assets | ¥96,105M | ¥97,479M | ¥95,832M | ¥100,140M |
| Total Equity | ¥66,154M | ¥63,968M | ¥64,661M | ¥66,708M |
| Total Liabilities | ¥29,951M | ¥33,511M | ¥31,171M | ¥33,432M |
| Cash | ¥18,718M | ¥17,612M | ¥13,185M | ¥22,573M |
| Interest-bearing Debt | ¥3,100M | ¥6,188M | ¥3,601M | ¥7,187M |
| Equity Ratio | 68.84% | 65.62% | 67.47% | 66.61% |
| D/E Ratio | 0.05 | 0.10 | 0.06 | 0.11 |
| Cash Flow | ||||
| Operating CF | ¥8,840M | ¥6,970M | ¥6,496M | ¥9,311M |
| Investing CF | ¥591M | -¥368M | -¥1,928M | ¥850M |
| Financing CF | -¥5,163M | -¥7,284M | -¥9,038M | -¥659M |
| Free CF | ¥7,688M | ¥5,816M | ¥4,921M | ¥7,522M |
| Efficiency | ||||
| ROE | 10.89% | 12.68% | 11.60% | 12.34% |
| ROA | 7.49% | 8.32% | 7.83% | 8.22% |
Latest IR Information
-
Notice of Consolidated Monthly Performance for March 2026 (Preliminary Report)
Consolidated sales for March 2026 increased 16.2% year-over-year to exceed 10 billion yen in a single month. All segments recorded significant sales growth: Laboratory +14.6%, Industry +18.1%, Medical +19.3%.
Read more -
Notice of Completion of Treasury Stock Cancellation
As One Corporation completed the cancellation of 340,000 shares of treasury stock (0.45% of total issued shares) on March 31, 2026. After cancellation, the total number of issued shares stood at 75,012,540 shares.
Read more -
Announcement of Consolidated Monthly Performance for February 2026 (Flash Report)
Consolidated sales for February 2026 increased by 5.1% year-over-year. Laboratory sector grew by 6.4%, Industry by 6.6%, while Medical declined by 2.2%.
Read more -
Notice on Cancellation of Treasury Stock (Cancellation of Treasury Stock Based on Article 178 of the Companies Act)
AS ONE Corporation resolved to cancel 340,000 shares of common stock (0.45% of total issued shares) as treasury stock on March 31, 2026.
Read more -
Notice of January 2026 Standalone Monthly Performance (Preliminary)
Standalone sales for January 2026 increased 6.8% year-over-year. The Laboratory segment grew by 10.6%, Industry by 4.9%, and Medical declined by 4.1%.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥3,350
Rating Score: 2.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. The company offers scientific instruments comprising temperature/humidity control and measuring/surveying instruments, as well as universal products used for cooling, heating, mixing, absorption, pressurization, and conveyance; microscopes, glass slides, and tissue culture products for biotechnology; magnifying glasses indispensable for precision work, plus filters, and dispensing devices required for analysis technology; equipment indispensable for research facilities, such as experimental platforms, fume hoods, and pharmaceutical depositories, as well as storage equipment, wagons, laboratory chairs, and conveyance equipment; containers required for storage or preservation of samples, reagents, materials, and others; glass or plastic beakers, flask indispensables, hoses, tubes, and joints; tapes and labels; and timers, packaging machines, tools, office supplies, and other equipment for laboratories. It also provides industrial instruments, such as dehumidifying storage products; equipment for organization, conveyance, etc.; equipment for sterilization/disinfecting and cleaning, including ultrasonic cleaners for washing/drying, detergents, and drying tools; glasses, masks, and gloves; and tools and containers used in clean rooms, as well as dust-proof and anti-static products comprising clean room clothes and mats indispensable. In addition, the company offers hospital/nursing instruments, such as white gowns, masks, and gloves; rack systems for installing in nursing stations; various products, supplies, and equipment required for hospital nursing and care; and sterilizers and sterilization lockers, as well as care cars and beds, and bathing and sanitary products. The company was founded in 1933 and is headquartered in Osaka, Japan.